Biotech filed for bankruptcy 11 weeks before its big FDA decision
You can be right about the science and still lose every dollar you put in. That is the hardest lesson in small-cap investing, and it shows up in credit agreements and amendment schedules, not in press releases. Here is how the game usually works. A young drug company raises money against a future event, an
